rss
Evid Based Nurs 12:57 doi:10.1136/ebn.12.2.57
  • Treatment

High-dose vitamin B supplements did not slow cognitive decline in patients with mild-to-moderate Alzheimer disease

P S Aisen

Dr P S Aisen, University of California, San Diego, CA, USA; paisen@ucsd.edu

QUESTION

Do high-dose vitamin B supplements reduce rate of cognitive decline in patients with Alzheimer disease (AD)?

METHODS

Design:

randomised placebo controlled trial. Clinicaltrials.gov NCT00056225.

Allocation:

{concealed}.*

Blinding:

blinded (patients, caregivers, clinicians, and psychometrists).

Follow-up period:

every 3 months up to 18 months.

Setting:

40 centres in the USA.

Patients:

409 patients >50 years of age (mean age 76 y, 56% women), who had probable AD, scored 14–26 on the Mini-Mental State Examination (MMSE), and were medically stable. Exclusion criteria were vitamin B12 concentrations <129 pmol/l (175 pg/ml), folate concentrations <9.5 nmol/l (4.2 ng/ml), renal insufficiency (serum creatinine ⩾176.8 µmol/l [2.0 mg/dl]), …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article